ReviewRSC advances2026
Recent advances of azomethine ylides for the synthesis of natural and synthetic bioactive pyrrolidines and spiropyrrolidines.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
1,3-Dipole-based nitrogen containing carbanion, particularly azomethine ylide, is widely used in cycloaddition reactions. It has important and widespread application not only limited in the synthesis of core structural motifs like pyrrolidine and spiropyrrolidines but also in stereocontrolled dipolarophile for building important classes of heterocyclic compounds. Herein, we will explore the current development of azomethine ylide and all the possible applications of this small but elegant fragment using a green approach. This review article will also covers the application of this super energetic, pharmaceutically important moiety in the field of asymmetric, organocatalytic, and transition metal-catalyzed synthesis processes coupled with a theoretical approach. The development of an environmentally safe multicomponent, tandem synthesis method mediated by azomethine ylide will be discussed in detail in this current review article, which will be important for researchers in the field of organic synthesis, heterocyclic chemistry, and medicinal chemistry.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.